BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21522098)

  • 1. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial.
    Gomes VO; Poli de Figueredo CE; Caramori P; Lasevitch R; Bodanese LC; Araújo A; Röedel AP; Caramori AP; Brito FS; Bezerra HG; Nery P; Brizolara A
    Heart; 2005 Jun; 91(6):774-8. PubMed ID: 15894775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study.
    Palli E; Makris D; Papanikolaou J; Garoufalis G; Tsilioni I; Zygoulis P; Zakynthinos E
    Crit Care; 2017 Oct; 21(1):269. PubMed ID: 29089038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Patients With Renal Insufficiency.
    Liu Y; Li H; Chen S; Chen J; Tan N; Zhou Y; Liu Y; Ye P; Ran P; Duan C; Chen P
    J Am Heart Assoc; 2016 May; 5(6):. PubMed ID: 27233298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Curcuminoids on Contrast-Induced Acute Kidney Injury after Elective Coronary Angiography or Intervention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
    Noppakun K; Jitraknatee J; Suteeka Y; Ruengorn C; Nochaiwong S; Gunaparn S; Phrommintikul A; Wongcharoen W
    Cardiorenal Med; 2024; 14(1):160-166. PubMed ID: 38350427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization.
    Kumar A; Bhawani G; Kumari N; Murthy KS; Lalwani V; Raju ChN
    J Clin Diagn Res; 2014 Dec; 8(12):HC03-7. PubMed ID: 25653965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nicorandil and ranolazine in prevention of contrast-induced nephropathy in patients with mild-to-moderate renal dysfunction: a randomized controlled trial.
    Yusuf J; Prakash G; Safal S; Mehta V; Mukhopadhyay S
    Coron Artery Dis; 2024 May; 35(3):186-192. PubMed ID: 38411168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial.
    Gholoobi A; Sajjadi SM; Shabestari MM; Eshraghi A; Shamloo AS
    Electron Physician; 2015 Dec; 7(8):1557-65. PubMed ID: 26816582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis.
    Meregildo-Rodriguez ED; Asmat-Rubio MG; Vásquez-Tirado GA
    Front Endocrinol (Lausanne); 2023; 14():1307715. PubMed ID: 38179307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.
    Ye Z; Lu H; Guo W; Dai W; Li H; Yang H; Li L
    Medicine (Baltimore); 2016 Nov; 95(46):e5306. PubMed ID: 27861357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis.
    Bagshaw SM; Ghali WA
    BMC Med; 2004 Oct; 2():38. PubMed ID: 15500690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy - a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial.
    Biernacka-Fiałkowska B; Szuksztul M; Suślik W; Dzierwa K; Tekieli Ł; Kostkiewicz M; Podolec P; Pieniążek P
    Postepy Kardiol Interwencyjnej; 2018; 14(1):59-66. PubMed ID: 29743905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology.
    Goldfarb S; McCullough PA; McDermott J; Gay SB
    Mayo Clin Proc; 2009 Feb; 84(2):170-9. PubMed ID: 19181651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary restriction for prevention of contrast-induced acute kidney injury in patients undergoing percutaneous coronary angiography: a randomized controlled trial.
    Grundmann F; Müller RU; Hoyer-Allo KJR; Späth MR; Passmann E; Becker I; Pfister R; Baldus S; Benzing T; Burst V
    Sci Rep; 2020 Mar; 10(1):5202. PubMed ID: 32251303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Randomized Trial of Na/K Citrate for the Prevention of Contrast-Induced Nephropathy in High-risk Patients.
    Iranirad L; Sadeghi MS; Hejazi SF
    Med J Islam Repub Iran; 2024; 38():27. PubMed ID: 38783979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydration therapy and nursing intervention on preventing contrast-induced nephropathy after interventional treatment of lower extremity arteriosclerosis obliterans.
    Chen J; Zhang X; Wu W; Yuan Y; Xue W; Cao W; Du R
    Technol Health Care; 2024; 32(3):1361-1369. PubMed ID: 38073340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency.
    Ye Z; Lu H; Su Q; Xian X; Li L
    Oncotarget; 2017 Nov; 8(60):102521-102530. PubMed ID: 29254267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Remnant Cholesterol and Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and/or Percutaneous Coronary Intervention.
    Luo B; Huang X; Peng Y; Luo H; Chen L; Lin Y
    Angiology; 2024 Jan; ():33197231225862. PubMed ID: 38185982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Contrast-induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention.
    Pranata R; Wahyudi DP
    Curr Cardiol Rev; 2023 Oct; 20(1):. PubMed ID: 37877506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-induced nephropathy in interventional cardiology.
    Sudarsky D; Nikolsky E
    Int J Nephrol Renovasc Dis; 2011; 4():85-99. PubMed ID: 21912486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.